Busulfan
| Generic name | Busulfan |
| Pronunciation | byoo-SUL-fan |
| Brand name(s), other common name(s) | Busulfex®, Myleran® |
| Drug type | DNA-damaging agent |
| How the drug is given | By mouth or intravenously (IV) |
Busulfan is FDA approved in combination with cyclophosphamide as a conditioning regimen prior to allogeneic stem cell transplantation for people who have chronic myeloid leukemia.
Side effects needing medical attention:
Fever, chills, or sore throat; unusual bleeding or bruising; cough; joint pain; shortness of breath; swelling of feet or lower legs; black, tarry stools; blood in urine or stool; pinhead-sized red spots on skin; lower back or side pain; painful or difficult urination; sores in mouth and on lips; darkening of the skin; confusion; diarrhea; dizziness; loss of appetite; nausea and vomiting; unusual tiredness; weakness; weight loss.Side effects needing medical attention after stopping this medication: Fever; cough; shortness of breath; unusual bleeding or bruising; black, tarry stools; blood in urine or stool; chills; hoarseness; lower back or side pain; painful or difficult urination; pinhead-sized red spots on skin.
For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.
